Venture capital investment manager Deepbridge Capital has completed its latest Life Sciences SEIS GBP1 million funding round.
Companies receiving seed-stage funding include Carocell Bio, Circada, FlutterLab, GenoMe Diagnostics, Glucose Republic and NanOptima.
The Deepbridge Life Sciences SEIS enables private investors to access a portfolio of early-stage companies within the UK’s vibrant life sciences sector, whilst benefiting from the generous potential tax reliefs available via the Government’s Seed Enterprise Investment Scheme (SEIS).
Deepbridge also manages the Deepbridge Life Sciences EIS, the Deepbridge Technology Growth EIS and the Deepbridge Innovation SEIS.
Read more/Source: Private Equity Wire
